Chair
Executive Committee
Vice Chair
Chris Garabedian
Chairman & CEO, Xontogeny
Treasurer
Michael O’Hara
Partner, Deloitte
Counsel
Larry Wittenberg
Partner, Goodwin
Clerk
Tamar Thompson
Head, Corporate Affairs, Alexion/AstraZeneca Rare Disease
Immediate Past Chair
Charles Wilson
Immediate Past Chair, MassBio
Directors
Cheryl Blanchard
President & CEO, Anika Therapeutics, Inc.
Melissa Bradford-Klug
President & Chief Business Officer, RareStone Inc.
Tim P. Clackson
President & CEO, Theseus Pharmaceuticals
Chip Clark
President & CEO, Genocea Biosciencs, Inc.
Sharon Cload
Vice President, Discovery Biotherapeutics, East Coast, Bristol Myers Squibb
Jason Cole
Chief Strategy and Financial Officer, bluebird bio
Robert Coughlin
Managing Director, Life Sciences, JLL
John Dunlop
Head of Research & Development, Neumora
Jeff Elton
CEO, Concerto AI
Barbara S. Fox
CEO, Rheos Medicines
Gary Gillheeney
President & CEO, Organogenesis Inc.
Robert Gottlieb
Principal, RMG Associates
Luba Greenwood
Managing Partner, Dana-Farber Cancer Institute, Binney Street Capital; CEO
Jose-Carlos Gutierrez-Ramos
Chief Science Officer, Danaher Corporation
Sue Hager
Chief Marketing Officer, Andreessen Horowitz (a16z) Bio+Health
Martin Heidecker
Chief Investment Officer, AMR Action Fund
Ed Kaye
CEO, Stoke Therapeutics
Chris Leibman
SVP, Value and Access, Biogen
Lizabeth Leveille
Vice President and Head, BD&L Boston & European Innovation Hubs, Merck & Co., Inc.
Liz Lewis
Head of Global Oncology Patient Value, Policy and Access, Takeda
Alice Lin Pomponio
Managing Director, American Cancer Society’s BrightEdge Fund
David Lucchino
Co-founder, President & CEO, Frequency Therapeutics
David Meeker
Chair, President & CEO, Rhythm Pharmaceuticals
Gilmore O’Neill
President & CEO, Editas Medicine
William P. McDermott
Partner, McDermott, Quilty & Miller LLP
Cindy Perettie
Head, Roche Molecular Labs
Adelene Perkins
Chair & CEO, Infinity Pharmaceuticals
Michal Preminger
Head, Johnson & Johnson Innovation, East North America
Chandra Ramanathan
Global Head, Innovation Hubs, Danaher
Eric Rasmussen
Vice President, Government Relations & Public Affairs, Sunovion
Amit K. Sachdev
Executive VP, CPO, COS, Vertex
Bill Sibold
Executive Vice President & Head, Sanofi Genzyme
Kumar Srinivasan
Executive Vice President & CBO, Turning Point Therapeutics
